SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

CORRESP Filing

ARTELO BIOSCIENCES, INC.
Date: March 20, 2026 · CIK: 0001621221 · Accession: 0001640334-26-000506

Offering / Registration Process

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-294506

Date
March 20, 2026
Author
Gregory D. Gorgas
Form
CORRESP
Company
ARTELO BIOSCIENCES, INC.

Letter

artl_corresp.htm Artelo Biosciences, Inc. 505 Lomas Santa Fe, Suite 160 Solana Beach, CA 92075 March 20, 2026 U.S. Securities and Exchange Commission 100 F Street, N.E. Washington, DC. 20549 Attn: Doris Stacey Gama Re: Artelo Biosciences, Inc. Registration Statement on Form S-1 (File No. 333-294506) Ladies and Gentlemen, Pursuant to Rule 461 under the Securities Act of 1933, as amended, Artelo Biosciences, Inc. hereby respectfully requests that the Securities and Exchange Commission accelerate the effectiveness of the above-referenced Registration Statement on Form S-1 (the “Registration Statement”) and declare such Registration Statement effective at 5:00 p.m. (Eastern Time) on Tuesday, March 24, 2026, or as soon thereafter as practicable. It would be appreciated if, as soon as the Registration Statement is declared effective, you would so inform Louis A. Bevilacqua of Bevilacqua PLLC at (202) 869-0888, ext. 100. Respectfully, Artelo Biosciences, Inc. By: /s/ Gregory D. Gorgas Gregory D. Gorgas Chief Executive Officer cc: Louis A. Bevilacqua, Esq.

Show Raw Text
CORRESP
 1
 filename1.htm

 artl_corresp.htm Artelo Biosciences, Inc. 505 Lomas Santa Fe, Suite 160 Solana Beach, CA 92075 March 20, 2026 U.S. Securities and Exchange Commission 100 F Street, N.E. Washington, DC. 20549 Attn: Doris Stacey Gama Re: Artelo Biosciences, Inc. Registration Statement on Form S-1 (File No. 333-294506) Ladies and Gentlemen, Pursuant to Rule 461 under the Securities Act of 1933, as amended, Artelo Biosciences, Inc. hereby respectfully requests that the Securities and Exchange Commission accelerate the effectiveness of the above-referenced Registration Statement on Form S-1 (the “Registration Statement”) and declare such Registration Statement effective at 5:00 p.m. (Eastern Time) on Tuesday, March 24, 2026, or as soon thereafter as practicable. It would be appreciated if, as soon as the Registration Statement is declared effective, you would so inform Louis A. Bevilacqua of Bevilacqua PLLC at (202) 869-0888, ext. 100. Respectfully, Artelo Biosciences, Inc. By: /s/ Gregory D. Gorgas Gregory D. Gorgas Chief Executive Officer cc: Louis A. Bevilacqua, Esq.